doi: 10.1016/j.vaccine.2011.06.001 153 SeyamaMYoshidaKYoshidaKFujiwaraNOnoKEguchiTet al
10.1016/0006-3002(55)90218-3 [DOI] [PubMed] [Google Scholar] Hoagland MB, Stephenson ML, Scott JF, Hecht LI, Zamecnik PC
To explore whether the reduced ferroptosis sensitivity of NPC cells caused by EBV infection depends on the upregulated expression of GPX4, we used two specific shRNAs to knockdown endogenous GPX4 (Fig
While glutathione is generally considered safe, it is essential to consult with a healthcare professional to determine the appropriate dosage and frequency for your needs
The pharmacokinetics result of embodiment 41:CoQ10 topical therapeutic With 72 BALB/c mouse random assortment to 8 group (group I-IX), every group of 8 mices.Group I handles.At the 0th day, with 5mg/cm 2 Speed with 0.1g test sample (the oil-in-water emulsifiable paste Emulsion that comprises the 3%w/w CoQ10 emulsifiable paste of supporting by the arm the radiolabeled API 31510 of C-14) Local treatment group II-VIII.Radioactivity API 31510 is added 3% emulsifiable paste has the specific activity of about 50 Ci/g products or 5 Ci/ application dosages in batches with generation experimental cream preparation.Give the skin of back local application test sample of each mice of group II-IX with Glass rod.The II of execution group immediately animal after the administration is collected blood, urine, feces and the target organ (liver, pancreas and spleen) of measuring amount and weighs.Processing blood is to obtain serum, with each organ homogenization.The the 2nd, 4,8,12,18 and 24 hour execution group III-VIII after administration collects identical sample respectively.With 0.1g test sample Local treatment group IX, carry out 7 days (0-6 days).At the 7th day, after finally using test sample 24 hours, execution group I and IIX were as collecting identical sample for previous group.Measure the per minute decays (DPM) of each sample and calculate the average DPM/ sample type of each group
